Paper Details
- Home
- Paper Details
Effect of rifaximin on gut-lung axis in mice infected with influenza A virus.
Author: ChenYafei, JiangZuoyi, LeiZhihai, PingJihui, SuJuan
Original Abstract of the Article :
Gut-lung axis injury is a common finding in patients with respiratory diseases as well as in animal model of influenza virus infection. Influenza virus damages the intestinal microecology while affecting the lungs. Rifaximin, a non-absorbable derivative of rifamycin, is an effective antibiotic that ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.cimid.2021.101611
データ提供:米国国立医学図書館(NLM)
Gut-Lung Axis: A Symphony of Microbes and Immunity
The field of [immunology] is constantly uncovering the complex interactions between the immune system and the microbiome. This study explores the interplay between the gut and lung, known as the gut-lung axis, in the context of influenza virus infection. The authors investigated the potential protective effects of rifaximin, a non-absorbable antibiotic, on the gut-lung axis in mice infected with influenza A virus. They conducted [experimental studies] to examine the impact of rifaximin on the gut microbiome, the integrity of the gut and lung barriers, and the inflammatory response to influenza infection.
Rifaximin's Role: Rebalancing the Microbiome
The study reveals that rifaximin treatment significantly reduced the severity of lung and intestinal damage caused by influenza virus infection. Rifaximin modulated the composition of the gut microbiome, increasing populations of beneficial bacteria like Lactobacillus and Bifidobacterium while decreasing populations of harmful bacteria like Escherichia coli. The study also observed that rifaximin strengthened the physical barriers of the gut and lung, reducing permeability and promoting the expression of tight junction proteins.
A Holistic Approach: From Gut to Lung
This study highlights the importance of the gut-lung axis in regulating immune responses to infections. It suggests that targeting the gut microbiome with rifaximin may offer a novel therapeutic strategy to mitigate the severity of influenza virus infection. Further research is needed to explore the potential applications of rifaximin in clinical settings.
Dr.Camel's Conclusion
Just as a desert ecosystem is a delicate balance of flora and fauna, the human body is a complex network of interconnected systems. This study demonstrates the profound impact of the gut microbiome on lung health, highlighting the importance of a holistic approach to managing infections. By understanding the intricate interplay between the gut and lung, we can develop innovative strategies to enhance immune function and promote overall well-being.
Date :
- Date Completed 2021-05-24
- Date Revised 2021-05-24
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.